Tumor necrosis factor-α is central to acute cigarette smoke-induced inflammation and connective tissue breakdown

American Journal of Respiratory and Critical Care Medicine

Volumn 166, Issue 6, 2002, Pages 849-854

  Churg, Andrew ^a   Dai, Jin ^a   Tai, Hsin ^a   Xie, Changshi ^a   Wright, Joanne L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

COPD; Macrophage chemoattractant protein 1; Macrophage inflammatory protein 2; Polymorphisms; TNF

Indexed keywords

COLLAGEN; ELASTIN; HYDROXYPROLINE; MACROPHAGE CHEMOATTRACTANT PROTEIN 1; MACROPHAGE INFLAMMATORY PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; COLLAGEN METABOLISM; CONTROLLED STUDY; DNA POLYMORPHISM; EMPHYSEMA; GENE EXPRESSION; GENE OVEREXPRESSION; INFLAMMATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TISSUE NECROSIS; TRANSGENIC MOUSE;

ANALYSIS OF VARIANCE; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DENSITOMETRY; DESMOSINE; GENE EXPRESSION; INFLAMMATION; IRRIGATION; LUNG; MACROPHAGE INFLAMMATORY PROTEINS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, TUMOR NECROSIS FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMOKING; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037106511     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200202-097OC     Document Type: Article

References (39)

1. Sakao S, Tatsumi K, Igari H, Shino Y, Shirasawa H, Kuriyama T. Association of tumor necrosis factor α gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163:420-422.
2. Huang SL, Su CH, Chang SC. Tumor necrosis factor-α gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 1998;156:1436-1439.
3. Keatings VM, Cave SJ, Henry MJ, Morgan K, O'Connor CM, FitzGerald MX, Kalsheker N. A polymorphism in the tumor necrosis factor-α gene promoter region may predispose to a poor prognosis in COPD. Chest 2000;118:971-975.
4. Higham MA, Pride NB, Alikhan A, Morrell NW. Tumour necrosis factor-α gene promoter polymorphisms in chronic obstructive pulmonary disease. Eur Respir J 2000;15:281-284.
5. Sandford AJ, Chagani T, Weir TD, Connett JE, Anthonisen NR, Pare PD. Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med 2001;163:469-473.
6. Ishii T, Matsuse T, Teramoto S, Matsui H, Miyao M, Hosoi T, Takahashi H, Fukuchi Y, Ouchi Y. Neither IL-1β, IL-1 receptor antagonist, nor TNFα polymorphisms are associated with susceptibility to COPD. Respir Med 2000;94:847-851.
7. Kuschner WG, D'Alessandro A, Wong H, Blanc PD. Dose-dependent cigarette smoking-related inflammatory responses in healthy adults. Eur Respir J 1996;9:1989-1994.
8. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996;153:530-534.
9. Takabatake N, Nakamura H, Abe S, Inoue S, Hino T, Saito H, Yuki H, Kato S, Tomoike H. The relationship between chronic hypoxemia and activation of the tumor necrosis factor-α system in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000;161:1179-1184.
10. Takabatake N, Nakamura H, Inoue S, Terashita K, Yuki H, Kato S, Yasumura S, Tomoike H. Circulating levels of soluble Fas ligand and soluble Fas in patients with chronic obstructive pulmonary disease. Respir Med 2000;94:1215-1220.
11. Bresser P, Out TA, van Alphen L, Jansen HM, Lutter R. Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic Haemophilus influenzae airway infection. Am J Respir Crit Care Med 2000;162:947-952.
12. McCrea KA, Ensor JE, Nall K, Bleecker ER, Hasday JD. Altered cytokine regulation in the lungs of cigarette smokers. Am J Respir Crit Care Med 1994;150:696-703.
13. Dubar V, Gosset P, Aerts C, Voisin C, Wallaert B, Tonnel AB. In vitro acute effects of tobacco smoke on tumor necrosis factor α and interleukin-6 production by alveolar macrophages. Exp Lung Res 1993;19:345-359.
14. 2. Hum Exp Toxicol 1997;16:577-588.
15. Kotani N, Hashimoto H, Sessler DI, Yatsu Y, Muraoka M, Matsuik A. Exposure to cigarette smoke impairs alveolar macrophage functions during halothane and isoflurane anesthesia in rats. Anesthesiology 1999;91:1823-1833.
16. Ouyang T, Virasch N, Hao P, Aubrey MT, Mukerjee N, Bierer BE, Freed BM. Suppression of human IL-1β, IL-2, IFN-γ, and TNFα production by cigarette smoke extracts. J Allergy Clin Immunol 2000;106:280-287.
17. Morimoto Y, Kdo M, Tanaka I, Fujino A, Higashi T, Yokosaki Y. Synergistic effects of mineral fibres and cigarette smoke on the production of tumour necrosis factor by alveolar macrophages of rats. Br J Ind Med 1993;50:955-960.
18. Lucey EC, Keane J, Kuang P-P, Snider GL, Goldstein RH. Severity of elastase-induced emphysema is decreased in tumor necrosis factor-α and interleukin-1β receptor-deficient mice. Lab Invest 2002;82:79-85.
19. Dhami R, Gilks B, Xie C, Zay K, Wright J, Churg A. Acute cigarette smoke-induced connective tissue breakdown is mediated by neutrophils and prevented by α-1-antitrypsin. Am J Respir Cell Mol Biol 2000;22:244-252.
20. 1 expression in the lungs of inbred mice that fail to develop fibroproliferative lesions consequent to asbestos exposure. Am J Pathol 1999;154:853-862.
21. Li K, Keeling B, Churg A. Mineral dusts cause collagen and elastin breakdown in the rat lung: a potential mechanism of dust-induced emphysema. Am J Respir Crit Care Med 1996;153:644-649.
22. Chomczynski P, Sacchi N. Single step method of RNA isolation. Anal Biochem 1987;162:156-159.
23. Dai J, Gilks B, Price K, Churg A. Mineral dusts directly induce epithelial and interstitial fibrogenic mediators and matrix components in the airway wall. Am J Respir Crit Care Med 1998;158:1907-1913.
24. Davis GS, Pfeiffer LM, Hemenway DR. Persistent overexpression of interleukin-1β and tumor necrosis factor-α in murine silicosis. J Environ Pathol Toxicol Oncol 1998;17:99-114.
25. Zhao Q, Simpson LG, Driscoll KE, Keikauf GD. Chemokine regulation of ozone-induced neutrophil and monocyte inflammation. Am J Physiol 1998;274:L39-L46.
26. Peschon JJ, Torrance DS, Stocking KL, Glaccum MB, Otten C, Willis CR, Charrier K, Morrissey PJ, Ware CB, Mohler KM. TNFα receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J Immunol 1998;160:943-952.
27. Wewers MD, Gadek JE, Marsh CB. Pro-inflammatory cytokines. In: Crystal RG, Barnes PJ, West JB, Weibel ER, editors. The lung, 2nd ed. Philadelphia: Lippincott-Raven; 1997. p. 117-132.
28. Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassalli P. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 1989;170:655-663.
29. Piguet PF, Collart MA, Grau GE, Sappino AP, Vassalli P. Requirement for tumor necrosis factor for development of silica-induced pulmonary fibrosis. Nature 1990;344:245-247.
30. Ortiz LA, Lasky J, Hamilton RF, Holian A, Hoyle GW, Banks W, Peschon JJ, Brody AR, Lungarella G, Friedman M. Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice. Exp Lung Res 1998;24:721-743.
31. Liu JY, Brass DM, Hoyle GW, Brody AR. TNFα receptor knockout mice are protected from the fibroproliferative effects of inhaled asbestos fibers. Am J Pathol 1998;153:1839-1847.
32. 1. Exp Mol Pathol 2001;71:13-33.
33. 1 overexpression in tumor necrosis factor-α receptor knockout mice induces fibroproliferative lung disease. Am J Respir Cell Mol Biol 2001;25:3-7.
34. 1 in the lungs of asbestos-exposed rats and mice: reduced expression in TNFα receptor knockout mice. J Environ Pathol Toxicol Oncol 2001;20:97-108.
35. Maier LA, Sawyer RT, Bauer RA, Kittle LA, Lympany P, McGrath D, Dubois R, Daniloff E, Rose CS, Newman LS. High beryllium-stimulated TNFα is associated with the -308 TNFα promoter polymorphism and with clinical severity in chronic beryllium disease. Am J Respir Crit Care Med 2001;164:1192-1199.
36. Yucesoy B, Vallyathan V, Landsittel DP, Sharp DS, Weston A, Burleson GR, Semeonova P, McKinstry M, Luster MI. Association of tumor necrosis factor-α and interleukin-1 gene polymorphisms with silicosis. Toxicol Appl Pharmacol 2001;172:75-82.
37. Shapiro SD. Evolving concepts in the pathogenesis of chronic obstructive pulmonary disease. Clin Chest Med 2000;21:621-632.
38. Churg A, Dai J, Zay K, Karsan A, Hendricks R, Yee C, Martin R, MacKenzie R, Xie C, Zhang L, et al. α-1-Antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute antiinflammatory effects. Lab Invest 2001;81:1119-1131.
39. Fugita M, Shannon JM, Irvin CG, Fagan KA, Cool C, Augustin A, Mason RJ. Overexpression of tumor necrosis factor-α produces an increase in lung volumes and pulmonary hypertension. Am J Physiol 2001;280:L39-L49.